Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2015 by University of Washington
Sponsor:
Collaborators:
National Cancer Institute (NCI)
National Comprehensive Cancer Network
Information provided by (Responsible Party):
University of Washington
ClinicalTrials.gov Identifier:
NCT00823797
First received: January 15, 2009
Last updated: September 1, 2015
Last verified: September 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: February 2016 (Final data collection date for primary outcome measure)